Inhibition of Isorhamnetin on β-Catenin/Tcf Signaling and β-Catenin-Activated Melanogenesis
PDF

Keywords

β-catenin/Tcf signaling; inhibitor;isorhamnetin, melanogenesis.

How to Cite

Seyeon Park, Hana Choi, & Yun Joo Kim. (2021). Inhibition of Isorhamnetin on β-Catenin/Tcf Signaling and β-Catenin-Activated Melanogenesis. Journal of Basic & Applied Sciences, 9, 401–409. https://doi.org/10.6000/1927-5129.2013.09.51

Abstract

Activated β-catenin/T-cell factor (Tcf) signaling plays various roles in human cell mechanisms. We identified the inhibitory effect of isorhamnetin against β-catenin/Tcf signaling in β-catenin activated cells. Isorhamnetin inhibited the transcriptional activity of β-catenin/Tcf in HEK293 cells transiently transfected with a constitutively active mutant β-catenin gene. Also, isorhamnetin inhibited theβ-catenin-activated melanogenesis in B16F1 cells. Regarding the inhibitory mechanism, the shift assay showed that the binding of Tcf complexes with its specific DNA-binding sites was suppressed byisorhamnetin. Western blot analysis showed a decreased level of β-catenin in nucleus caused by isorhamnetin. These results suggest that the isorhamnetin acts as a negative regulator of β-catenin/Tcf signaling and its inhibitory mechanism is related to the decreased binding of β-catenin/Tcf complexes to consensus DNA.

https://doi.org/10.6000/1927-5129.2013.09.51
PDF

References

Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. Constitutive transcriptional activation by a b-catenin–Tcfcomplex in APC_/_colon carcinoma. Science 1997; 275(5307): 1784-7. http://www.ncbi.nlm.nih.gov/pubmed/ 9065401 http://dx.doi.org/10.1126/science.275.5307.1784

Morin PJ, Sparks AB, Korinek V, Barker N, Clever H, et al. Activation of b-catenin–Tcf signaling in colon cancer by mutations in b-catenin or APC. Science 1997; 275: 1787-89. http://www.sciencemag.org/content/275/5307/1787.short http://dx.doi.org/10.1126/science.275.5307.1787

Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88. http://www.annualreviews.org/doi/abs/10.1146/annurev.cellbio.14.1.59 http://dx.doi.org/10.1146/annurev.cellbio.14.1.59

Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51. http://genesdev.cshlp.org/content/14/15/1837.short

Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398(6726): 422-6. http://www.nature.com/nature/journal/v398/n6726/abs/ 398422a0.html http://dx.doi.org/10.1038/18884

Zhang F, White RL, Neufeld KL. Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol 2001; 21(23): 8143-56. http://mcb.asm.org/content/21/23/8143. Short http://dx.doi.org/10.1128/MCB.21.23.8143-8156.2001

Mareel M, Boterberg T, Noe V, Van Hoorde L, Vermeulen S, et al. E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion. J Cell Physiol 1997; 173: 2714. http://dx.doi.org/10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G

Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, et al. Binding of GSK3b to the APC–β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-26. http://dx.doi.org/10.1126/science.272.5264.1023

Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression andmutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95 (2): 108-13. http://dx.doi.org/10.1002/1097-0215(20010320)95:2<108::AID-IJC1019>3.0.CO;2-#

Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for theubiquitinproteasome pathway. EMBO J 1997; 16: 3797-804. http://www.nature.com/emboj/ journal/v16/n13/abs/7590356a.html http://dx.doi.org/10.1093/emboj/16.13.3797

Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, Udono T, et al. Induction of melanocyte-specific microphthalmiaassociated transcription factor by Wnt-3a. J Biol Chem 2000; 275: 14013-16. http://www.jbc.org/content/ 275/19/14013.short http://dx.doi.org/10.1074/jbc.C000113200

Cho M, Ryu M, Jeong Y, Chung YH, Kim DE, Cho HS, et al. Cardamonin suppresses melanogenesis by inhabitation of Wnt/β-catenin signaling. Biochem Biophys Res Commun 2009; 390(3): 500-5. http://www.sciencedirect.com/science/ article/pii/S0006291X0901941X http://dx.doi.org/10.1016/j.bbrc.2009.09.124

Vance KW, Goding CR. The transcription network regulating melanocyte development and melanoma. Pigment Cell Res 2004; 17: 318-25. http://dx.doi.org/10.1111/j.1600-0749.2004.00164.x

Dorsky RI, Raible DW, Moon RT. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 2000; 14: 158-62. http://genesdev.cshlp.org/content/14/2/158.short

Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S. Functional analysis of microphthalmia-associated transcription factor in pigment cellspecific transcription of the human tyrosinase family genes. J Biol Chem 1997; 272(1): 503-9. http://www.jbc.org/content/272/1/ 503.short http://dx.doi.org/10.1074/jbc.272.1.503

Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP, Ballotti R. Microphthalmia gene product as a signal transducer in camp-induced differentiation of melanocytes. J Cell Biol 1998; 142(3): 827-35. http://jcb.rupress.org/content/142/3/827.abstract http://dx.doi.org/10.1083/jcb.142.3.827

Aksan I, Goding CR. Targeting the microphthalmia basic helix-loop-helixleucine zipper transcription factor to a subset of E-box element in vitro and in vivo. Mol Cell Biol 1998; 18(12): 6930-8. http://mcb.asm.org/content/18/12/6930.short

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281(5382): 1509-12. http://www.sciencemag. org/content/281/5382/1509.short http://dx.doi.org/10.1126/science.281.5382.1509

Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, et al. Target genes of β-catenin–T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. PNAS 1999; 96 (4): 1603-8. http://www.pnas.org/content/96/4/1603.short http://dx.doi.org/10.1073/pnas.96.4.1603

Bohm, BA, Stuessy TF. Flavonoids of the sunflower family (Asteraceae). Springer 2001; 597.

Sanchez M, Lodi F, Vera R, Villar IC, Cogolludo A, et al. Quercetin and Isorhamnetin Prevent Endothelial Dysfunction, Superoxide Production, and Overexpression of p47phox Induced by Angiotensin II in Rat Aorta. J Nutr 2007; 137(4): 910-5. http://jn.nutrition.org/content/137/4/910.short

Ma G, Yang C, Qu Y, Wei H, Zhang T, et al. The flavonoidcomponent isorhamnetin in vitro inhibits proliferation and inducesapoptosis in Eca-109 cells. Chem Biol Interact 2007; 167(2): 153-60. http://www.sciencedirect.com/science/ article/pii/S0009279707000440 http://dx.doi.org/10.1016/j.cbi.2007.02.006

Lee SK, Kwon BM, Baek NI, Kim SH, Lee JH, et al. Antiproliferation effects of isorhamnetin isolated from Persicaria thunbergii on cancer cell lines. Nat Prod Sci 2006; 12(4): 214-6. http://www.papersearch.net/view/detail.asp? detail_key=05004194

Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010; 29(3):

-34. http://link.springer.com/article/10.1007/s10555-010-9235-2#page-1 http://dx.doi.org/10.1007/s10555-010-9235-2

Steffen Y, Gruber C, Schewe T, Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 2008; 469(2): 209-19. http://www.sciencedirect.com/science/article/pii/ S0003986107005139 http://dx.doi.org/10.1016/j.abb.2007.10.012

Kim JE, Lee DE, Lee KW, Son JE, Seo SK, Li J, et al. Isorhamnetin Suppresses Skin Cancer through Direct Inhibition of MEK1 and PI3-K. Cancer Prev Res 2011; 4(4): 582-91. http://cancerprevres.aacrjournals.org/content/4/4/ 582.short http://dx.doi.org/10.1158/1940-6207.CAPR-11-0032

Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, et al. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem 2007; 102(6): 1529-41. http://dx.doi.org/10.1002/jcb.21373

Rose DP, Connolly JM. Effects of Fatty Acids and Inhibitors of Eicosanoid Synthesis on the Growth of a Human Breast Cancer Cell Line in Culture. Cancer Res 1990; 50: 7139-44. http://cancerres.aacrjournals.org/content/50/22/7139.short

Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat P-A, et al. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. Oncogene 2011; 30: 423-33. http://dx.doi.org/10.1038/onc.2010.432

Yamaguchi Y, Itami S, Watabe H, Yasumoto K, Abdel-Malek ZA, Kudo T, et al. Mesenchymal–epithelial interaction in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 2004; 165(2): 275-85. http://jcb.rupress.org/content/ 165/2/275.abstract http://dx.doi.org/10.1083/jcb.200311122

Yamaguchi Y, Passeron T, Watabe H, Yasumoto K, Rouzaud F, Hoashi T, et al. The effects of dickkopf1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. J Invest Dermatol 2007; 127: 1217-25. http://dx.doi.org/10.1038/sj.jid.5700629

Clapper ML, Coudry J, Chang WCL. β -catenin-mediated signaling: A molecular target for early chemopreventive intervention. Mutat Res 2004; 555(1-2): 97-105. http://www. sciencedirect.com/science/article/pii/S0027510704002854 http://dx.doi.org/10.1016/j.mrfmmm.2004.05.021

Li F, Pham JD, Anderson MO, Youngren JF. Nordihydro-guaiaretic acid inhibits transforming growth factor β type 1 receptor activity and downstream signaling. Eur J Pharmacol 2009; 616(1-3): 31-7. http://www.sciencedirect.com/science/ article/pii/S0014299909005421 http://dx.doi.org/10.1016/j.ejphar.2009.06.012

Yang F, Hua Y, Du Y. Synthesis of biantennary β-D-(1→6) glucosamine oligosaccharides. Carbohydr Res 2003; 338(12): 1313-8. http://www.sciencedirect.com/science/ article/pii/S0008621503001708 http://dx.doi.org/10.1016/S0008-6215(03)00170-8

Park CH, Chang JY, Hahm ER. Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 2005; 328(1): 227-34. http://www.sciencedirect.com/science/ article/pii/S0006291X04029808 http://dx.doi.org/10.1016/j.bbrc.2004.12.151

Park CH, Hahm ER, Park S, Kim HK, Yang CH. The Inhibitory mechanism of curcumin and its derivative against b-catenin/Tcf signaling. FEBS Lett 2005; 579(13): 2965-71.

http://www.sciencedirect.com/science/article/pii/S0014579305004734 http://dx.doi.org/10.1016/j.febslet.2005.04.013

Lee JH, Park CH, Jung KC, Rhee HS, Yang CH. Negative regulation of b-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. Biochem Biophys Res Commun 2005; 335(3): 771-6. http://www.sciencedirect.com/science/article/ pii/S0006291X05016050 http://dx.doi.org/10.1016/j.bbrc.2005.07.146

Park S, Choi JM. Inhibition of b-Catenin/Tcf Signaling by Flavonoids. J Cell Biochem 2010; 110(6): 1376-85. http://dx.doi.org/10.1002/jcb.22654

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.